510(k) Report

510(k) · Cleared

Recalled · Class II · 2016

Trueresult Blood Glucose System E4H01-81

K080641510(k) TraditionalCleared Aug 19, 2008166-day reviewClass II21 CFR 862.1345Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Home Diagnostics, Inc. · NBW System, Test, Blood Glucose, Over The Counter

Cleared on Aug 19, 2008 after a 166-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 4 later devices descend from it. It has been recalled once.

Decided
Aug 19, 2008
Review
166 days
Class
Class II
Product code
NBW
Recalls
1
Predicates
0

4 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2012: 1 descendant cleared2011: 1 descendant cleared2009: 1 descendant cleared2013: 1 descendant cleared20052010201520202025
  1. This deviceK080641 Trueresult Blood Glucose System E4H01-81Home Diagnostics, Inc. · 2008
  2. Descendant · cites it directly · 1 of its ownK122435 Nova One Blood Glucose MonitorNova Biomedical Corporation · 2012
  3. Descendant · 2 generations on · 0 of its ownK131013 Focus Blood Glucose Monitoring System, Focus Pro Blood Glucose…Nova Biomedical Corporation · 2013
  4. Descendant · cites it directly · 0 of its ownK112352 Glucose Meter-Check Control for Nipro TrueresultBionostics, Inc. · 2011
  5. Descendant · cites it directly · 0 of its ownK091460 Abt Glucose Control Solution Level 1,2,3 Model, 2120083,2120086…American Biological Technologies, Inc. · 2009

Most influential descendants

Showing 4 of 4 · See all
  • K122435Nova One Blood Glucose MonitorNova Biomedical Corporation · 2012 · cites it directly1descendant
  • K131013Focus Blood Glucose Monitoring System, Focus Pro Blood Glucose Monitoring SystemNova Biomedical Corporation · 2013 · 2 generations on0descendants
  • K112352Glucose Meter-Check Control for Nipro TrueresultBionostics, Inc. · 2011 · cites it directly0descendants
  • K091460Abt Glucose Control Solution Level 1,2,3 Model, 2120083,2120086, 2120087American Biological Technologies, Inc. · 2009 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K080641Trueresult Blood Glucose System E4H01-81Home Diagnostics, Inc.2008—
+1K122435Nova One Blood Glucose MonitorNova Biomedical Corporation2012—
+2K131013Focus Blood Glucose Monitoring System, Focus Pro Blood Glucose Monitoring SystemNova Biomedical Corporation2013—
+1K112352Glucose Meter-Check Control for Nipro TrueresultBionostics, Inc.2011—
+1K091460Abt Glucose Control Solution Level 1,2,3 Model, 2120083,2120086, 2120087American Biological Technologies, Inc.2009—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200910
201110
201210
201310
FIG. 1 — Lineage of K080641, 2008–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NBW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBW device

  1. #1 K260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring…score 14.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (4)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K122435Nova One Blood Glucose MonitorNova Biomedical Corporation20121
K112352Glucose Meter-Check Control for Nipro TrueresultBionostics, Inc.20110
K091460Abt Glucose Control Solution Level 1,2,3 Model, 2120083,2120086, 2120087American Biological Technologies, Inc.20090

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jun 28, 2016Class IIZ-2880-2016Nonconforming Material/ComponentProduct gives incorrect low blood glucose levels.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K122435 (Nova Biomedical Corporation, 2012) has gone furthest, with 1 descendant of its own.

How does its category compare?

All NBW devices

NBW System, Test, Blood Glucose, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · NBW

2in 2025

2007: 292008: 372009: 382010: 312011: 302012: 302013: 472014: 242015: 322016: 202017: 252018: 192019: 102020: 72021: 72022: 122023: 52024: 72025: 22026 (partial year): 5
2007high 47 (2013) · low 2 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBW

243in 2024

2007: 85 days median2008: 128 days median2009: 140 days median2010: 132 days median2011: 328 days median2012: 230 days median2013: 167 days median2014: 202 days median2015: 237 days median2016: 233 days median2017: 244 days median2018: 168 days median2019: 127 days median2020: 121 days median2021: 465 days median2022: 410 days median2023: 193 days median2024: 243 days median2026 (partial year): 190 days median
2007high 465 (2021) · low 85 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBW

1in 2025

2007: 92008: 22009: 52010: 112011: 12012: 12013: 5, 2 Class I2014: 12016: 12019: 142025: 1
2007high 14 (2019) · low 0 (2015)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · NBW

4,745in 2025

2007: 7,9912008: 7,7042009: 10,9632010: 11,6312011: 22,9092012: 23,4492013: 35,4082014: 38,5242015: 62,1112016: 76,6212017: 37,5382018: 16,9112019: 14,4722020: 10,7032021: 9,1982022: 8,1032023: 7,2562024: 6,2202025: 4,745
2007high 76,621 (2016) · low 4,745 (2025)2025

MAUDE reports naming product code NBW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007298597,991
20083712827,704
200938140510,963
2010311321111,631
201130328122,909
201230230123,449
2013471675 (2)35,408
201424202138,524
201532237062,111
201620233176,621
201725244037,538
201819168016,911
2019101271414,472
20207121010,703
2021746509,198
20221241008,103
2023519307,256
2024724306,220
20252—14,745
202651900—

What is it indicated for?

The TRUEresult Blood Glucose System is intended for the quantitative determination of glucose in human whole blood taken from the finger or forearm. The System is intended to be used to assist the patient and Healthcare Professional in the management of diabetes.

Healthcare Professionals may use the device to test venous whole blood; home-use is limited to capillary whole blood testing.

Not for neonatal use.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K080641: Trueresult Blood Glucose System E4H01-81.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K080641

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026